VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LXRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LXRXLexicon Pharmaceuticals, Inc.
$2.37$1.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLXRXQuarterly Financials

Lexicon Pharmaceuticals, Inc. (LXRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Lexicon Pharmaceuticals, Inc. (LXRX) quarterly income statement — complete revenue, gross profit & net income history

LXRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue21.1M5.49M14.18M28.87M1.26M26.55M1.75M1.65M1.13M702K162K317K24K28K39K35K37K14K23K234K
Revenue Growth %1572.11%-79.31%710.4%1652.64%11.68%3682.62%980.25%419.56%4608.33%2407.14%315.38%805.71%-35.14%100%69.57%-85.04%37.04%-92.96%-99.65%-97.45%
Cost of Goods Sold108K319K10K209K30K25.93M71K166K175K14.83M7K8K0103K00109K16.5M010.26M
COGS % of Revenue0.51%5.81%0.07%0.72%2.38%97.66%4.06%10.08%15.49%2112.82%4.32%2.52%-367.86%--294.59%117842.86%-4383.33%
Gross Profit20.99M5.17M14.17M28.66M1.23M621K1.68M1.48M955K-14.13M155K309K24K-75K39K35K-72K-16.48M23K-10.02M
Gross Margin %99.49%94.19%99.93%99.28%97.62%2.34%95.94%89.92%84.51%-2012.82%95.68%97.48%100%-267.86%100%100%-194.59%-117742.86%100%-4283.33%
Gross Profit Growth %1604.06%733.17%744.07%1834.98%29.01%104.39%983.23%379.29%3879.17%-18740%297.44%782.86%133.33%99.54%69.57%100.35%99.43%-1978.69%-99.62%-218.83%
Operating Expenses21.99M19.95M26.36M24.92M26.91M33.36M65.37M56.84M46.29M32.61M49.79M44.55M31.17M30.2M23.13M24.04M23.31M8.85M22.98M7.94M
OpEx % of Revenue104.21%363.26%185.86%86.33%2132.41%125.62%3735.54%3450.82%4096.28%4644.87%30732.1%14053.31%129858.33%107867.86%59317.95%68691.43%62994.59%63185.71%99934.78%3391.45%
Selling, General & Admin9.23M8.76M7.6M9.35M11.61M039.59M39.19M32.06M032.23M30.01M19.14M16.33M12.58M10.69M8.49M07.3M0
SG&A % of Revenue43.76%159.42%53.6%32.39%919.81%-2262.4%2379.6%2837.17%-19893.83%9466.25%79750%58317.86%32248.72%30531.43%22948.65%-31752.17%-
Research & Development12.76M11.2M18.76M15.57M15.3M26.68M25.78M17.64M14.23M14.76M17.56M14.54M12.03M13.87M10.56M13.36M14.82M16.5M15.68M10.26M
R&D % of Revenue60.45%203.84%132.26%53.94%1212.6%100.49%1473.14%1071.22%1259.12%2102.85%10838.27%4587.07%50108.33%49550%27069.23%38160%40045.95%117842.86%68182.61%4383.33%
Other Operating Expenses000001000K0001000K0000000-1000K0-1000K
Operating Income-996K-14.78M-12.19M3.74M-25.68M-32.74M-63.69M-55.35M-45.33M-46.74M-49.63M-44.24M-31.14M-30.28M-23.09M-24.01M-23.38M-25.33M-22.96M-17.96M
Operating Margin %-4.72%-269.07%-85.93%12.94%-2034.79%-123.28%-3639.6%-3360.9%-4011.77%-6657.69%-30636.42%-13955.84%-129758.33%-108135.71%-59217.95%-68591.43%-63189.19%-180928.57%-99834.78%-7674.79%
Operating Income Growth %96.12%54.85%80.87%106.75%43.35%29.95%-28.33%-25.12%-45.57%-54.36%-114.9%-84.28%-33.2%-19.53%-0.58%-33.68%-12.19%-239.64%-126.49%72.19%
EBITDA-996K-14.66M-12.04M3.91M-25.5M-32.61M-63.57M-55.22M-45.19M-46.59M-49.48M-44.1M-31.03M-30.18M-22.99M-23.9M-23.27M-25.22M-22.86M-17.92M
EBITDA Margin %-4.72%-266.92%-84.87%13.55%-2020.84%-122.81%-3632.4%-3352.46%-3999.03%-6636.75%-30543.21%-13910.41%-129291.67%-107767.86%-58941.03%-68285.71%-62894.59%-180128.57%-99395.65%-7656.84%
EBITDA Growth %96.09%55.04%81.07%107.09%43.56%30%-28.47%-25.22%-45.63%-54.4%-115.25%-84.5%-33.34%-19.66%-0.55%-33.39%-11.87%-326.41%-126.14%71.86%
D&A (Non-Cash Add-back)0118K151K176K176K125K126K139K144K147K151K144K112K103K108K107K109K112K101K42K
EBIT-996K-14.78M-10.61M5.57M-23.46M-20.44M-60.25M-51.22M-44.6M-45.3M-46.63M-42.94M-30.11M-29.39M-22.52M-23.88M-23.37M-25.33M-22.95M-17.96M
Net Interest Income1.59M-750K-582K-484K384K-1.03M-1.12M1.93M-3.06M-3.02M-894K-664K-792K-216K-292K-580K-96K-281K-160K-108K
Interest Income01.28M1.57M1.83M2.22M2.83M3.44M4.14M1.88M2.4M3M1.3M1.03M887K572K123K14K14K11K61K
Interest Expense-1.59M2.03M2.15M2.32M1.83M3.86M4.56M2.21M4.95M5.42M3.9M1.96M1.82M1.1M864K703K110K295K171K169K
Other Income/Expense-47K-750K-582K-484K384K-1.03M-1.12M1.93M-3.06M-3.02M-894K-664K-792K-216K-292K-580K-96K-281K-160K-108K
Pretax Income-1.04M-15.53M-12.77M3.25M-25.3M-33.77M-64.81M-53.43M-48.4M-49.76M-50.52M-44.9M-31.93M-30.49M-23.39M-24.59M-23.48M-25.61M-23.12M-18.07M
Pretax Margin %-4.94%-282.72%-90.04%11.27%-2004.36%-127.16%-3703.49%-3244.02%-4282.92%-7087.75%-31188.27%-14165.3%-133058.33%-108907.14%-59966.67%-70248.57%-63448.65%-182935.71%-100530.43%-7720.94%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.04M-15.53M-12.77M3.25M-25.3M-33.77M-64.81M-53.43M-48.4M-49.76M-50.52M-44.9M-31.93M-30.49M-23.39M-24.59M-23.48M-25.61M-23.12M-18.07M
Net Margin %-4.94%-282.72%-90.04%11.27%-2004.36%-127.16%-3703.49%-3244.02%-4282.92%-7087.75%-31188.27%-14165.3%-133058.33%-108907.14%-59966.67%-70248.57%-63448.65%-182935.71%-100530.43%-7720.94%
Net Income Growth %95.88%54.01%80.3%106.09%47.73%32.14%-28.28%-18.98%-51.55%-63.17%-116.04%-82.63%-36.03%-19.07%-1.15%-36.09%-12.01%-366.08%-127.99%73.84%
Net Income (Continuing)-1.04M-15.53M-12.77M3.25M-25.3M-33.77M-64.81M-53.43M-48.4M-49.76M-50.52M-44.9M-31.93M-30.49M-23.39M-24.59M-23.48M-25.61M-23.12M-18.07M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.00-0.04-0.040.01-0.07-0.09-0.18-0.17-0.20-0.20-0.21-0.22-0.16-0.16-0.14-0.17-0.16-0.17-0.16-0.13
EPS Growth %96.29%52.56%80.5%105.24%65%55%14.29%22.73%-25%-25%-50%-29.41%0%5.88%12.5%-30.77%-6.67%-278.62%-122.54%80%
EPS (Basic)-0.00-0.04-0.040.01-0.07-0.09-0.18-0.17-0.20-0.20-0.21-0.22-0.16-0.16-0.14-0.17-0.16-0.17-0.16-0.13
Diluted Shares Outstanding400.24M363.43M363.4M363.57M362.07M361.49M361.49M310.84M245.39M244.93M244.93M204.78M189.01M188.73M174.9M149.62M149.15M148.9M145.82M144.45M
Basic Shares Outstanding400.24M363.43M363.4M363.29M362.07M361.49M361.49M310.84M245.39M244.93M244.93M204.78M189.01M188.73M174.9M149.62M149.15M148.9M145.82M144.45M
Dividend Payout Ratio--------------------